NFKB1 and polycystic kidney disease: Previous studies have shown that AQP1 is involved in other pathophysiological mechanisms such as tumor development, inflammatory cytokine release (via the NF-κB pathway), and polycystic kidney disease (via the Wnt pathway) [75,76,77].